<DOC>
	<DOCNO>NCT02267629</DOCNO>
	<brief_summary>This research study test whether GLYX-13 - experimental drug act brain receptor call NMDA - decrease symptom OCD within hour . This treatment study . Results study allow doctor researcher well understand others OCD may respond class medication target NMDA brain receptor .</brief_summary>
	<brief_title>Open Label Trial Rapastinel ( Formerly GLYX-13 ) Individuals With Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>Inclusion Criteria Patients No medication Washout : Age 1855 Physically healthy currently pregnant Primary Diagnosis OCD currently psychotropic medication drug Able provide inform consent Exclusion Criteria Patients No Medication Washout : Psychiatric condition make participation unsafe ( schizophrenia [ either self first degree relative e.g . sibling , parent ] , history violence , severe depression , eat disorder , substance abuse prior year [ include nicotine ] , lifetime substance dependence disorder [ except nicotine ] ) Female patient either pregnant nursing Enrolled plan enroll Cognitive Behavioral Therapy . Medical condition make participation unsafe ( e.g. , high blood pressure , head injury ) Currently medication make participation unsafe History allergy , sensitivity , intolerance NmethylDaspartate receptor ( NMDAR ) ligands include ketamine , dextromethorphan , memantine , methadone , destropropoxyphene , ketobemidone . Inclusion Criteria Patients Medication Washout : Age 1855 Physically healthy currently pregnant Primary Diagnosis OCD Currently adequate dose medication treatment OCD , achieve least partial remission able handle medication washout . Able provide inform consent Exclusion Criteria Patients Medication Washout : Psychiatric condition make participation unsafe ( schizophrenia [ either self first degree relative e.g . sibling , parent ] , history violence , severe depression , eat disorder , substance abuse prior year [ include nicotine ] , lifetime substance dependence disorder [ except nicotine ] ) Female patient either pregnant nursing Enrolled plan enroll CognitiveBehavioral Therapy . Patient judge unlikely able tolerate medication washout . Medical condition make participation unsafe ( e.g. , high blood pressure , head injury ) Currently medication make participation unsafe History allergy , sensitivity , intolerance NmethylDaspartate receptor ( NMDAR ) ligands include ketamine , dextromethorphan , memantine , methadone , destropropoxyphene , ketobemidone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>OCD</keyword>
</DOC>